A loss-of-function mutation in natriuretic peptide receptor 2 (Npr2) gene is responsible for disproportionate dwarfism in cn/cn mouse

被引:107
作者
Tsuji, T [1 ]
Kunieda, T [1 ]
机构
[1] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan
关键词
D O I
10.1074/jbc.C500024200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The achondroplastic mouse is a spontaneous mutant characterized by disproportionate dwarfism with short limbs and tail due to disturbed chondrogenesis during endochondral ossification. These abnormal phenotypes are controlled by an autosomal recessive gene (cn). In this study, linkage analysis using 115 affected mice of F-2 progeny mapped the cn locus on an similar to 0.8-cM region of chromosome 4, and natriuretic peptide receptor 2 (Npr2) gene was identified as the most potent candidate for the cn mutant in this region. This gene encodes a receptor for C-type natriuretic peptide (CNP) that positively regulates longitudinal bone growth by producing cGMP in response to CNP binding to the extracellular domain. Sequence analyses of the Npr2 gene in cn/cn mice revealed a T to G transversion leading to the amino acid substitution of highly conserved Leu with Arg in the guanylyl cyclase domain. In cultured chondrocytes of cn/cn mice, stimulus with CNP did not significantly increase intracellular cGMP concentration, whereas it increased in +/+ mice. Transfection of the mutant Npr2 gene into COS-7 cells also showed similar results, indicating that the missense mutation of the Npr2 gene in cn/cn mice resulted in disruption of the guanylyl cyclase activity of the receptor. We therefore concluded that the dwarf phenotype of cn/cn mouse is caused by a loss-of-function mutation of the Npr2 gene, and cn/cn mouse will be a useful model to further study the molecular mechanism regulating endochondral ossification by CNP/natriuretic peptide receptor B signal.
引用
收藏
页码:14288 / 14292
页数:5
相关论文
共 34 条
[21]   Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II [J].
Pfeifer, A ;
Aszodi, A ;
Seidler, U ;
Ruth, P ;
Hofmann, F ;
Fassler, R .
SCIENCE, 1996, 274 (5295) :2082-2086
[22]   Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia [J].
Ridanpää, M ;
van Eenennaam, H ;
Pelin, K ;
Chadwick, R ;
Johnson, C ;
Yuan, B ;
vanVenrooij, W ;
Pruijn, G ;
Salmela, R ;
Rockas, S ;
Mäkitie, O ;
Kaitila, I ;
de la Chapelle, A .
CELL, 2001, 104 (02) :195-203
[23]  
SANNASGALA SSMMK, 1990, J ANAT, V172, P245
[24]   THE PRIMARY STRUCTURE OF A PLASMA-MEMBRANE GUANYLATE-CYCLASE DEMONSTRATES DIVERSITY WITHIN THIS NEW RECEPTOR FAMILY [J].
SCHULZ, S ;
SINGH, S ;
BELLET, RA ;
SINGH, G ;
TUBB, DJ ;
CHIN, H ;
GARBERS, DL .
CELL, 1989, 58 (06) :1155-1162
[25]  
SILBERBERG R, 1975, GROWTH, V39, P17
[26]   Organ-specific mRNA distribution of C-type natriuretic peptide in neonatal and adult mice [J].
Stepan, H ;
Leitner, E ;
Bader, M ;
Walther, T .
REGULATORY PEPTIDES, 2000, 95 (1-3) :81-85
[27]   C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line [J].
Suda, M ;
Tanaka, K ;
Yasoda, A ;
Komatsu, Y ;
Chusho, H ;
Miura, M ;
Tamura, N ;
Ogawa, Y ;
Nakao, K .
JOURNAL OF BONE AND MINERAL METABOLISM, 2002, 20 (03) :136-141
[28]   RECEPTOR SELECTIVITY OF NATRIURETIC PEPTIDE FAMILY, ATRIAL-NATRIURETIC-PEPTIDE, BRAIN NATRIURETIC PEPTIDE, AND C-TYPE NATRIURETIC PEPTIDE [J].
SUGA, SI ;
NAKAO, K ;
HOSODA, K ;
MUKOYAMA, M ;
OGAWA, Y ;
SHIRAKAMI, G ;
ARAI, H ;
SAITO, Y ;
KAMBAYASHI, Y ;
INOUYE, K ;
IMURA, H .
ENDOCRINOLOGY, 1992, 130 (01) :229-239
[29]  
THURSTON MN, 1985, J ANAT, V140, P425
[30]   Inhibitory effect of C-type natriuretic peptide (CNP) on cultured cardiac myocyte hypertrophy: Interference between CNP and endothelin-1 signaling pathways [J].
Tokudome, T ;
Horio, T ;
Soeki, T ;
Mori, K ;
Kishimoto, I ;
Suga, SI ;
Yoshihara, F ;
Kawano, Y ;
Kohno, M ;
Kangawa, K .
ENDOCRINOLOGY, 2004, 145 (05) :2131-2140